Njira Lugogo, MD
Clinical Professor of Internal Medicine
Medical School
University of Michigan
Medicine
300 North Ingalls St Suite 2c40
Ann Arbor, Michigan 48109
[email protected]
Medicine
300 North Ingalls St Suite 2c40
Ann Arbor, Michigan 48109
Available to mentor
Njira Lugogo, MD
Clinical Professor
Manage Your Profile
Qualifications
-
MSDuke University, Durham, NC, United States
2012 - 2016
-
MDVirginia Commonwealth University, 1201 E Marshall St., 4th Floor P. O. Box 980565, Richmond, VA, 23298-0565, United States
1997 - 2001
-
BSVirginia Polytechnic Institute and State University, Blacksburg, VA, United States
1992 - 1996
Links
twitter https://miasthmaresearch.med.umich.edu/ https://scholar.google.com/scholar?hl=en&as_sdt=0%2C23&q=lugogo%2C+n&btnG= https://www.uofmhealth.org/profile/30571/njira-lucia-lugogo-md
Recent Publications
-
Lugogo NL, Trevor J, Spahn JD, Panettieri RA, Carstens DD, Ambrose CS. Journal of Asthma and Allergy, 2026 May 6; 19: 588118Journal ArticleMortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study
DOI:10.2147/jaa.s588118 -
Aegerter H, Brightling CE, Dunican EM, Lambrecht BN, Lugogo NL, Newell JD, Porsbjerg C, Svenningsen S, Clarke D, Lindsley AW, Nordenmark L, Ambrose CS, Castro M. Respiratory Research, 2026 Dec 1; 27 (1):Journal ArticleEffectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review
DOI:10.1186/s12931-026-03501-z PMID: 41559746 -
Panettieri RA, Mohan A, Lugogo NL, Ledford DK, Carstens DD, Ambrose CS. Respiratory Research, 2026 Dec 1; 27 (1):Journal ArticleOutcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study
DOI:10.1186/s12931-025-03439-8 PMID: 41501790 -
Mohan A, Panettieri RA, Moore WC, Lugogo NL, Zhou W, Lindsley AW, Carstens DD, Ambrose CS. Journal of Allergy and Clinical Immunology Global, 2026 Sep 1; 5 (5):Journal ArticleBiologic effectiveness increases with earlier biologic initiation after severe asthma onset
DOI:10.1016/j.jacig.2026.100746 -
Bosma CB, Aaron SD, Celli BR, Parraga G, Seymour S, Washko GR, Allinson JP, Baraldi F, Boucher RC, Castro M, Chotirmall SH, Diaz AA, Fahy JV, Goldin JG, Halayko AJ, Halpin DMG, Hoffman E, Labaki WW, Lugogo N, Kazerooni E, Kesimer M, Papi A, Ram S, Ramsey KA, San José Estépar R, Tanabe N, Whelan K, Wedzicha JA, Martinez FJ, Han MK. Am J Respir Crit Care Med, 2026 Jun 22;Journal ArticleAirway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical Trials.
DOI:10.1093/ajrccm/aamag309 PMID: 42330343 -
Lugogo NL, Akuthota P, Sumino K, Burnette AF, Mathur SK, Lindsley AW, Llanos Ackert J-P, Marchese C, Ambrose CS, Emmanuel B. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.049Journal ArticleB32-46 Tezepelumab in Diverse Real-World Patients With Severe Asthma Across Different Phenotypes and Underrepresented Populations: Final Results From the US Phase 4 PASSAGE Study
DOI:10.1093/ajrccm/aamag286.049 -
Dunican EM, Castro M, Papi A, Backer V, Brightling CE, Bourdin A, Virchow JC, Altincatal A, Gall R, Awad H, Lugogo NL. Am J Respir Crit Care Med, 2026 May 24;Journal ArticleReply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.
DOI:10.1093/ajrccm/aamag221 PMID: 42178814 -
Busse WW, Castro M, Lugogo NL, O'Byrne PM, Bacharier LB, Xia C, Ledanois O, Soliman M. Ann Allergy Asthma Immunol, 2026 May 23;Journal ArticleImproved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroids.
DOI:10.1016/j.anai.2026.05.019 PMID: 42178021
Featured News & Stories
Health Lab
Using biologic injections for severe asthma after COVID
Biologic injections end up being the best treatment for treating severe asthma after having COVID for one patient.
